Hormone replacement therapy tablets increase heart disease risks in menopausal women

In Sweden, researchers conducted a study published in the British Medical Journal that analyzed the health effects of hormone replacement therapy (HRT) on menopausal women. The study focused on a cohort of 919,000 Swedish women aged 50 to 58 over a two-year period. The researchers aimed to determine the link between HRT usage and the occurrence of heart problems, particularly focusing on the associated risks of heart disease and blood clots. The findings revealed that 'combined' hormone replacement therapy tablets containing both oestrogen and progestogen posed a significantly higher risk of cardiovascular issues compared to other forms of HRT. In contrast, gels and creams used as hormone replacement showed no increase in heart-related problems, indicating that the mode of delivery of HRT plays a crucial role in its safety profile. This study adds to the existing body of evidence regarding the risks associated with different types of HRT. The implications of these results are vital for both healthcare providers and patients. As menopausal women often seek hormone replacement therapy to alleviate symptoms, it is important that they are made aware of the potential risks, particularly when opting for combined tablets. Healthcare professionals are encouraged to review these findings and discuss the safest options available to their patients, emphasizing the need for personalized approaches in prescribing HRT. Overall, this research underscores the necessity of ongoing studies to fully understand the implications of various hormone replacement therapies while ensuring that women receive the most accurate information to guide their health choices during menopause.